To verify the impact of three genes on the prognosis of glioblastoma patients, we analyzed the TCGA-GBM database and found that high expression of LITAF and OSMR significantly shortened patient overall survival, while high expression of TCF12 significantly extended patient overall survival. This evidence concerns the gene LITAF and glioblastoma.